Treatment of schizophrenia with Ampakine and neuroleptics.

Use of a composition comprising a first compound that enhances the stimulation of receptors .alpha.-amino-3-hydroxy-5-methylisoxazole-4-propionic acid (AMPA?) in a subject and a second antipsychotic compound for the manufacture of a medicament for the treatment of schizophrenia.